University of Virginia School of Medicine

article

Inflammation discovery offers hope for age-related diseases

7 August 2023 | By Fraser Owen (Drug Target Review)

Researchers have made a significant breakthrough in the field of ageing research, uncovering a key driver of chronic inflammation that accelerates the ageing process.

news

UTX gene mutation “robs” individuals of natural cancer protection

10 November 2021 | By Anna Begley (Drug Target Review)

The UTX gene mutation was found to lead to an increased cancer risk, presenting a potential drug target for preventative therapies.

news

HIV drugs could be repurposed to prevent the onset of macular degeneration

2 February 2021 | By Hannah Balfour (Drug Target Review)

Analysis reveals people taking nucleoside reverse transcriptase inhibitors are significantly less likely to develop dry macular degeneration, a leading cause of age-related vision loss.

article

Five developments in oncology targets

30 July 2020 | By Hannah Balfour (Drug Target Review)

Drug Target Review explores some of the newest oncologic drug targets, including those for glioblastoma, lung cancer and breast cancer.

news

Study identifies potential drug target for prostate cancer

30 July 2019 | By Victoria Rees (Drug Target Review)

Researchers have discovered a non-coding RNA which could be used as a biomarker and in new therapies for prostate cancer.

news

Lymphatic brain vessels represent potential avenue for MS treatment

18 September 2018 | By Drug Target Review

Researchers in the U.S. have identified that lymphatic vessels in the brain appear to play a crucial role in the development and progression of multiple sclerosis (MS), providing focus for new treatment research.

news

Antibody-based approach to destroy deadly ovarian cancer

3 September 2018 | By Dr Zara Kassam (Drug Target Review)

Researchers are developing an antibody-based approach to destroy deadly ovarian cancer -- an approach that could also be modified to kill breast, prostate and other solid tumours...